|
|
Vol. 53, No. 9, September 2007, pp.1502 - 1507 Copyright © 2007 by The College of Family Physicians of Canada
Are patients with hyperlipidemia undertreated?Study of patients admitted to hospital with coronary eventsAlan H. Lipson, MD FRCPCSite Manager for the Critical Care and Medicine Programs at Victoria General Hospital in Winnipeg, Man, attends in the Department of Medicines Clinical Teaching Units at St Boniface General Hospital, is Medical Director of the Reh Fit Centre, and is a Lecturer in the Faculty of Medicine at the University of Manitoba
Wendy M. Fallis, RN PhD
Xiqui Wang, PhD PStat (SSC)
Yanqing Yi, MSc
Correspondence to: Dr Alan H. Lipson, Victoria General Hospital, 2340 Pembina Highway, Winnipeg, MB R3T 2E8; telephone 204 477–3217; fax 204 275–5100; e-mail alipson{at}vgh.mb.ca OBJECTIVE To identify patients admitted to hospital with coronary events and to estimate their pre-admission coronary risk, including their lipid levels. Despite the available data and numerous guidelines, evidence indicates that many patients with hyperlipidemia are undertreated and are not achieving target lipid levels. DESIGN Retrospective chart review. SETTING Acute care community hospital in Winnipeg, Man. PARTICIPANTS A total of 153 patients who were diagnosed with acute myocardial infarction, unstable angina, or acute coronary syndrome upon admission. METHOD Each patients 10-year risk of developing coronary artery disease was calculated, and his or her risk status was established. Each patients low-density lipoprotein cholesterol (LDL-C) levels were recorded and categorized based on current Canadian guidelines. RESULTS Mean age of patients was 67.6 years; 60.8% were male. Patients in the low-risk category had a mean LDL-C level of 2.98 mmol/L (95% confidence interval [CI] 2.66 to 3.29), and patients in the moderate-risk category had a mean LDL-C level of 3.01 mmol/L (95% CI 2.74 to 3.28), both significantly lower (P < .05) than the LDL-C target levels for patients in those risk categories according to Canadian guidelines. The mean LDL-C level for patients in the very high-risk category, however, was 2.53 mmol/L (95% CI 2.35 to 2.71), above the recommended goal. Almost half the patients (48.3%) in thevery high-risk category had LDL-C levels that exceeded the goal. Slightly more than 1 in 3 patients in the very high-risk category was reported to be taking lipid-lowering agents. CONCLUSION Patients in the community who are at very high risk of havingcardiovascular events are undertreated with respect to attaining LDL-C target levels. These findings point to an opportunity to prevent patient morbidity and reduce the number of hospitalizations for cardiovascular events.
|
|||||||||||||||||||||||||